Invention Application
US20080113921A1 Use of a Compound Comprising D-Mannoheptulose and/or Perseitol for Treating and Preventing Innate Immunity Modification Diseases
有权
包含D-甘露庚酮糖和/或Perseitol的化合物用于治疗和预防先天性免疫修饰疾病的用途
- Patent Title: Use of a Compound Comprising D-Mannoheptulose and/or Perseitol for Treating and Preventing Innate Immunity Modification Diseases
- Patent Title (中): 包含D-甘露庚酮糖和/或Perseitol的化合物用于治疗和预防先天性免疫修饰疾病的用途
-
Application No.: US11587961Application Date: 2005-04-29
-
Publication No.: US20080113921A1Publication Date: 2008-05-15
- Inventor: Antoine Piccirilli , Nathalie Piccardi , Philippe Msika , Francois Paul , Stéphanie Bredif
- Applicant: Antoine Piccirilli , Nathalie Piccardi , Philippe Msika , Francois Paul , Stéphanie Bredif
- Applicant Address: FR Courbevoie
- Assignee: LABORATOIRES EXPANSCIENCE
- Current Assignee: LABORATOIRES EXPANSCIENCE
- Current Assignee Address: FR Courbevoie
- Priority: FR0404635 20040430
- International Application: PCT/FR05/01075 WO 20050429
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/045
Abstract:
The invention relates to the use of a compound comprising D-mannoheptulose and/or perseitol for producing a drug for treating and/or preventing diseases related to the modification of an innate and/or acquired immunity by increasing the production of antimicrobial peptides, preferably hBD-2 without inducing inflammatory reactions, irritation or intolerance. Said compound can also comprise a peptidic avocado extract and/or a peptidic lupin extract.
Public/Granted literature
Information query
